US WorldMeds’ Eflornithine Gets US FDA Panel Nod For Pediatric Neuroblastoma

 
• By Sue Sutter
  
Boy looking out window
ODAC looked outside to an external control group for a demonstration of DFMO's efficacy in pediatric neuroblastoma. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers